| Literature DB >> 27605010 |
Kazunori Matsumura1, Hiroki Iwai1, Masako Kato-Miyazawa1, Fumiko Kirikae1, Jizi Zhao1, Toru Yanagawa2, Tetsuro Ishii2, Tohru Miyoshi-Akiyama1, Keiji Funatogawa3, Teruo Kirikae4.
Abstract
Peroxiredoxin (PRDX)1 is an antioxidant that detoxifies hydrogen peroxide and peroxinitrite. Compared with wild-type (WT) mice, Prdx1-deficient (Prdx1-/-) mice showed increased susceptibility to Mycobacterium tuberculosis and lower levels of IFN-γ and IFN-γ-producing CD4+ T cells in the lungs after M. tuberculosis infection. IL-12 production, c-Rel induction, and p38 MAPK activation levels were lower in Prdx1-/- than in WT bone marrow-derived macrophages (BMDMs). IFN-γ-activated Prdx1-/- BMDMs did not kill M. tubercuosis effectively. NO production levels were lower, and arginase activity and arginase 1 (Arg1) expression levels were higher, in IFN-γ-activated Prdx1-/- than in WT BMDMs after M. tuberculosis infection. An arginase inhibitor, Nω-hydroxy-nor-arginine, restored antimicrobial activity and NO production in IFN-γ-activated Prdx1-/- BMDMs after M. tuberculosis infection. These results suggest that PRDX1 contributes to host defenses against M. tuberculosis PRDX1 positively regulates IL-12 production by inducing c-Rel and activating p38 MAPK, and it positively regulates NO production by suppressing Arg1 expression in macrophages infected with M. tuberculosis.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27605010 DOI: 10.4049/jimmunol.1601010
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422